Parvovirus B19 in organ transplant recipients

Current Opinion in Organ Transplantation

Volumn 8, Issue 4, 2003, Pages 283-287

  Posfay Barbe, Klara M ^a   Michaels, Marian G ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Neutropenia; Parvovirus B19; Pure red blood cell anemia; Treatment

Indexed keywords

EID: 33846916561     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/00075200-200312000-00005     Document Type: Review

References (47)

1. Cossart YE, Field AM, Cant B, et al.: Parvovirus-like particles in human sera. Lancet 1975, 1:72-73.
2. Pattison JR, Jones SE, Hodgson J, et al.: Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet 1981, 1:664-665.
3. Flunker G, Peters A, Wiersbitzky S, et al.: Persistent parvovirus B19 infections in immunocompromised children. Med Microbiol Immunol (Berl) 1998, 186:189-194.
4. Calvet A, Pujol MO, Bertocchi M, et al.: Parvovirus B19 infection in thoracic organ transplant recipients. J Clin Virol 1999; 13:37-42.
5. Geetha D, Zachary JB, Baldado HM, et al.: Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature. Clin Transplant 2000, 14:586-591.
6. Broliden K: Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation. Pediatr Transplant 2001, 5:320-330.
7. Cohen BJ, Buckley MM: The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 1988, 25:151-153.
8. Kurtzman GJ, Cohen BJ, Field AM, et al.: Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 1989, 84:1114-1123.
9. Yango A Jr, Morrissey P, Gohh R, et al.: Donor-transmitted parvovirus infection in a kidney transplant recipient presenting as pancytopenia and allograft dysfunction. Transpl Infect Dis 2002, 4:163-166.
10. Mortimer PP, Luban NL, Kelleher JF, et al.: Transmission of serum parvoviruslike virus by clotting-factor concentrates. Lancet 1983, 2:482-484.
11. McOmish F, Yap PL, Jordan A, et al.: Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction. J Clin Microbiol 1993, 31:323-328.
12. Heegaard ED, Petersen BL, Heilmann CJ, et al.: Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy individuals. J Clin Microbiol 2002, 40:933-936.
13. Moudgil A, Shidban H, Nast CC, et al.: Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulin. Transplantation 1997, 64:1847-1850.
14. Moreux N, Ranchin B, Calvet A, et al.: Chronic parvovirus B19 infection in a pediatric lung transplanted patient. Transplantation 2002, 73:565-568.
15. Nour B, Green M, Michaels M, et al.: Parvovirus B19 infection in pediatric transplant patients. Transplantation 1993, 56:835-838.
16. Soderlund M, von Essen R, Haapasaari J, et al.: Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 1997, 349:1063-1065.
17. Gallinella G, Manaresi E, Venturoli S, et al.: Occurrence and clinical role of active parvovirus B19 infection in transplant recipients. Eur J Clin Microbiol Infect Dis 1999, 18:811-813.
18. Cavallo R, Merlino C, Re D, et al.: B19 virus infection in renal transplant recipients. J Clin Virol 2002, 26:361-368.
19. Murdock J, Morris TC, Alexander HD, et al.: Red cell aplasia due to erythrovirus parvovirus B19 infection in a Jehovah's witness with post-transplant EBV-induced aggressive lymphoma: management considerations. Leuk Lymphoma 2002, 43:211-213.
20. Neild G, Anderson M, Hawes S, et al.: Parvovirus infection after renal transplant. Lancet 1986, 2:1226-1227.
21. Corral DA, Darras FS, Jensen CW, et al.: Parvovirus B19 infection causing pure red cell aplasia in a recipient of pediatric donor kidneys. Transplantation 1993, 55:427-430.
22. Liefeldt L, Buhl M, Schweickert B, et al.: Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy. Nephrol Dial Transplant 2002, 17:1840-1842.
23. Barsoum NR, Bunnapradist S, Mougdil A, et al.: Treatment of parvovirus B-19 (PV B-19) infection allows for successful kidney transplantation without disease recurrence. Am J Transplant 2002, 2:425-428.
24. Janner D, Bork J, Baum M, et al.: Severe pneumonia after heart transplantation as a result of human parvovirus B19. J Heart Lung Transplant 1994, 13:336-338.
25. Morris CN, Smilack JD: Parvovirus B19 infection associated with respiratory distress. Clin Infect Dis 1998, 27:900-901.
26. Heegaard ED, Eiskjaer H, Baandrup U, et al.: Parvovirus B19 infection associated with myocarditis following adult cardiac transplantation. Scand J Infect Dis 1998, 30:607-610.
27. Moudgil A, Nast CC, Bagga A, et al.: Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int 2001, 59:2126-2133.
28. Zolnourian ZR, Curran MD, Rima BK, et al.: Parvovirus B19 in kidney transplant patients. Transplantation 2000, 69:2198-2202.
29. Wierenga KJ, Pattison JR, Brink N, et al.: Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease. Lancet 1995, 346:475-476.
30. Cooling LL, Koerner TA, Naides SJ: Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. J Infect Dis 1995, 172:1198-1205.
31. Brown KE, Anderson SM, Young NS: Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993, 262:114-117.
32. al Khaldi N, Watson AR, Harris A, et al.: Dual infection with human herpesvirus type 6 and parvovirus B19 in a renal transplant recipient. Pediatr Nephrol 1994, 8:349-350.
33. Marchand S, Tchernia G, Hiesse C, et al.: Human parvovirus B19 infection in organ transplant recipients. Clin Transplant 1999, 13:17-24.
34. Lee PC, Hung CJ, Lei HY, et al.: Parvovirus B19-related acute hepatitis in an immunosuppressed kidney transplant. Nephrol Dial Transplant 2000, 15:1486-1488.
35. Shan YS, Lee PC, Wang JR, et al.: Fibrosing cholestatic hepatitis possibly related to persistent parvovirus B19 infection in a renal transplant recipient. Nephrol Dial Transplant 2001, 16:2420-2422.
36. Lee PC, Hung CJ, Lin YJ, et al.: A role for chronic parvovirus B19 infection in liver dysfunction in renal transplant recipients? Transplantation 2002, 73:1635-1639.
37. Pardi DS, Romero Y, Mertz LE, et al.: Hepatitis-associated aplastic anemia and acute parvovirus B19 infection: a report of two cases and a review of the literature. Am J Gastroenterol 1998, 93:468-470.
38. Schowengerdt KO, Ni J, Denfield SW, et al.: Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction. Circulation 1997, 96:3549-3554.
39. Schowengerdt KO, Ni J, Denfield SW, et al.: Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction. J Heart Lung Transplant 1996, 15:111-123.
40. Cainelli F, Vento S: Infections and solid organ transplant rejection: a causeand- effect relationship? Lancet Infect Dis 2002, 2:539-549.
41. Porter HJ, Quantrill AM, Fleming KA: B19 parvovirus infection of myocardial cells. Lancet 1988, 1:535-536.
42. Wong TY, Chan PK, Leung CB, et al.: Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus. Am J Kidney Dis 1999, 34:1132-1136.
43. Ramage JK, Hale A, Gane E, et al.: Parvovirus B19-induced red cell aplasia treated with plasmapheresis and immunoglobulin. Lancet 1994, 343:667-668.
44. Corbett TJ, Saw H, Popat U, et al.: Successful treatment of parvovirus B19 infection and red cell aplasia occurring after an allogeneic bone marrow transplant. Bone Marrow Transplant 1995, 16:711-713.
45. Wiedbrauk DL, Bloom ME, Lodmell DL: Mink parvoviruses and interferons: in vitro studies. J Virol 1986, 60:1179-1182.
46. Frickhofen N, Young NS: Persistent parvovirus B19 infections in humans. Microb Pathog 1989, 7:319-327.
47. Brown KE, Young NS: Parvovirus B19 in human disease. Annu Rev Med 1997, 48:59-67.